SNBR

SNBR
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $342.879M ▲ | $245.704M ▲ | $-39.79M ▼ | -11.605% ▼ | $-1.73 ▼ | $-26.78M ▼ |
| Q2-2025 | $327.925M ▼ | $193.82M ▼ | $-25.012M ▼ | -7.627% ▼ | $-1.09 ▼ | $14.185M ▼ |
| Q1-2025 | $393.261M ▲ | $238.625M ▲ | $-8.646M ▼ | -2.199% ▼ | $-0.38 ▼ | $16.686M ▼ |
| Q4-2024 | $376.817M ▼ | $222.803M ▼ | $-4.665M ▼ | -1.238% ▼ | $-0.21 ▼ | $18.75M ▼ |
| Q3-2024 | $426.617M | $251.096M | $-3.136M | -0.735% | $-0.14 | $24.634M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.264M ▼ | $749.388M ▼ | $1.271B ▼ | $-521.342M ▼ |
| Q2-2025 | $1.349M ▼ | $804.512M ▼ | $1.285B ▼ | $-480.688M ▼ |
| Q1-2025 | $1.691M ▼ | $836.791M ▼ | $1.294B ▼ | $-456.844M ▼ |
| Q4-2024 | $1.95M ▲ | $860.81M ▼ | $1.312B ▼ | $-451.586M ▼ |
| Q3-2024 | $1.592M | $864.651M | $1.313B | $-448.784M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-39.79M ▼ | $-6.037M ▼ | $-3.836M ▲ | $9.788M ▲ | $-85K ▲ | $-9.873M ▼ |
| Q2-2025 | $-25.012M ▼ | $3.822M ▲ | $-6.733M ▼ | $2.569M ▼ | $-342K ▼ | $-2.911M ▲ |
| Q1-2025 | $-8.646M ▼ | $-2.626M ▲ | $-4.599M ▲ | $6.966M ▼ | $-259K ▼ | $-7.225M ▲ |
| Q4-2024 | $-4.665M ▼ | $-23.681M ▼ | $-6.287M ▼ | $30.326M ▲ | $358K ▲ | $-29.968M ▼ |
| Q3-2024 | $-3.136M | $27.306M | $-2.987M | $-24.747M | $-428K | $24.163M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|
Reportable Segment | $390.00M ▲ | $330.00M ▼ | $340.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Sleep Number combines a clearly differentiated, technology‑heavy product line and strong brand identity with a much weaker recent financial picture. Sales and profits have slipped from prior highs, and the company now operates close to breakeven, leaving less room to absorb shocks. The balance sheet is leveraged with negative equity and limited cash, which heightens financial risk if business conditions remain soft. Against this, its smart‑bed platform, data assets, and health‑oriented innovation strategy provide real strategic advantages that could support future growth if consumer demand stabilizes and the company can convert its innovations into sustainable, higher‑margin sales. Overall, it is a story of strong product differentiation and promising technology set against a tight financial position and cyclical end market.
NEWS
November 12, 2025 · 8:00 AM UTC
Sleep Number Earns J.D. Power Award, Ranked #1 in Customer Satisfaction with Mattresses Purchased In-Store and Online
Read more
November 5, 2025 · 7:00 AM UTC
Sleep Number Announces Third Quarter 2025 Results
Read more
October 16, 2025 · 8:31 AM UTC
Sleep Number to Participate in Upcoming December Investor Conferences
Read more
October 16, 2025 · 8:30 AM UTC
Sleep Number Corporation to Announce Third Quarter 2025 Results on November 5, 2025
Read more
About Sleep Number Corporation
https://www.sleepnumber.comSleep Number Corporation, together with its subsidiaries, offers sleep solutions and services in the United States. The company designs, manufactures, markets, retails, and services beds, pillows, sheets, and other bedding products under the Sleep Number name. It also provides adjustable bases under the FlextFit, and smart beds under the Sleep Number 360 brands.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $342.879M ▲ | $245.704M ▲ | $-39.79M ▼ | -11.605% ▼ | $-1.73 ▼ | $-26.78M ▼ |
| Q2-2025 | $327.925M ▼ | $193.82M ▼ | $-25.012M ▼ | -7.627% ▼ | $-1.09 ▼ | $14.185M ▼ |
| Q1-2025 | $393.261M ▲ | $238.625M ▲ | $-8.646M ▼ | -2.199% ▼ | $-0.38 ▼ | $16.686M ▼ |
| Q4-2024 | $376.817M ▼ | $222.803M ▼ | $-4.665M ▼ | -1.238% ▼ | $-0.21 ▼ | $18.75M ▼ |
| Q3-2024 | $426.617M | $251.096M | $-3.136M | -0.735% | $-0.14 | $24.634M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.264M ▼ | $749.388M ▼ | $1.271B ▼ | $-521.342M ▼ |
| Q2-2025 | $1.349M ▼ | $804.512M ▼ | $1.285B ▼ | $-480.688M ▼ |
| Q1-2025 | $1.691M ▼ | $836.791M ▼ | $1.294B ▼ | $-456.844M ▼ |
| Q4-2024 | $1.95M ▲ | $860.81M ▼ | $1.312B ▼ | $-451.586M ▼ |
| Q3-2024 | $1.592M | $864.651M | $1.313B | $-448.784M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-39.79M ▼ | $-6.037M ▼ | $-3.836M ▲ | $9.788M ▲ | $-85K ▲ | $-9.873M ▼ |
| Q2-2025 | $-25.012M ▼ | $3.822M ▲ | $-6.733M ▼ | $2.569M ▼ | $-342K ▼ | $-2.911M ▲ |
| Q1-2025 | $-8.646M ▼ | $-2.626M ▲ | $-4.599M ▲ | $6.966M ▼ | $-259K ▼ | $-7.225M ▲ |
| Q4-2024 | $-4.665M ▼ | $-23.681M ▼ | $-6.287M ▼ | $30.326M ▲ | $358K ▲ | $-29.968M ▼ |
| Q3-2024 | $-3.136M | $27.306M | $-2.987M | $-24.747M | $-428K | $24.163M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|
Reportable Segment | $390.00M ▲ | $330.00M ▼ | $340.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Sleep Number combines a clearly differentiated, technology‑heavy product line and strong brand identity with a much weaker recent financial picture. Sales and profits have slipped from prior highs, and the company now operates close to breakeven, leaving less room to absorb shocks. The balance sheet is leveraged with negative equity and limited cash, which heightens financial risk if business conditions remain soft. Against this, its smart‑bed platform, data assets, and health‑oriented innovation strategy provide real strategic advantages that could support future growth if consumer demand stabilizes and the company can convert its innovations into sustainable, higher‑margin sales. Overall, it is a story of strong product differentiation and promising technology set against a tight financial position and cyclical end market.
NEWS
November 12, 2025 · 8:00 AM UTC
Sleep Number Earns J.D. Power Award, Ranked #1 in Customer Satisfaction with Mattresses Purchased In-Store and Online
Read more
November 5, 2025 · 7:00 AM UTC
Sleep Number Announces Third Quarter 2025 Results
Read more
October 16, 2025 · 8:31 AM UTC
Sleep Number to Participate in Upcoming December Investor Conferences
Read more
October 16, 2025 · 8:30 AM UTC
Sleep Number Corporation to Announce Third Quarter 2025 Results on November 5, 2025
Read more

CEO
Linda A. Findley
Compensation Summary
(Year 2019)

CEO
Linda A. Findley
Compensation Summary
(Year 2019)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2006-06-09 | Forward | 3:2 |
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

STADIUM CAPITAL MANAGEMENT LLC
2.616M Shares
$13.344M

BLACKROCK INC.
1.621M Shares
$8.269M

BLACKROCK, INC.
1.491M Shares
$7.606M

VANGUARD GROUP INC
1.245M Shares
$6.348M

BRIGHTLIGHT CAPITAL MANAGEMENT LP
1.112M Shares
$5.67M

PACIFIC RIDGE CAPITAL PARTNERS, LLC
774.276K Shares
$3.949M

FMR LLC
765.772K Shares
$3.905M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
737.121K Shares
$3.759M

MILLENNIUM MANAGEMENT LLC
716.873K Shares
$3.656M

GOLDMAN SACHS GROUP INC
681.559K Shares
$3.476M

JACOBS LEVY EQUITY MANAGEMENT, INC
626.333K Shares
$3.194M

GEODE CAPITAL MANAGEMENT, LLC
505.839K Shares
$2.58M

INVENOMIC CAPITAL MANAGEMENT LP
485.966K Shares
$2.478M

STATE STREET CORP
454.633K Shares
$2.319M

BANK OF AMERICA CORP /DE/
433.971K Shares
$2.213M

PICTET ASSET MANAGEMENT LTD
389.256K Shares
$1.985M

DIMENSIONAL FUND ADVISORS LP
384.87K Shares
$1.963M

NUMERIC INVESTORS LLC
366.6K Shares
$1.87M

CUBIST SYSTEMATIC STRATEGIES, LLC
362.264K Shares
$1.848M

MORGAN STANLEY
331.049K Shares
$1.688M
Summary
Only Showing The Top 20




